Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
Background: Survival from melanoma is strongly related to patient sex, with females having a survival rate almost twice that of males. Many explanations have been proposed but have not withstood critical scrutiny. Prior analysis of different cancers with a sex bias has identified six X-linked genes...
Main Authors: | Abdullah Al Emran, Jérémie Nsengimana, Gaya Punnia-Moorthy, Ulf Schmitz, Stuart J. Gallagher, Julia Newton-Bishop, Jessamy C. Tiffen, Peter Hersey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/8/2082 |
Similar Items
-
Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
by: Gaya Punnia-Moorthy, et al.
Published: (2021-06-01) -
Epigenetic Control and Cancer: The Potential of Histone Demethylases as Therapeutic Targets
by: Jeison Garcia, et al.
Published: (2012-09-01) -
Tackling malignant melanoma epigenetically: histone lysine methylation
by: Elias Orouji, et al.
Published: (2018-11-01) -
CTCF binding protein and epigenetic regulations of genome
by: Mohammad Reza Mohammad Abadi, et al.
Published: (2013-11-01) -
Change of epigenetic modification and human reproduction
by: Jafar Nouri Nojadeh, et al.
Published: (2016-03-01)